Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iluvien in chronic diabetic macular edema (RESPOND)
NCT02359526Phase 4Completed
- Sponsor
- AIBILI
- Start
- Oct 2014
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluocinolone in diabetic macular edema (DME), sponsored by AIBILI. Started Oct 2014; status: completed.
02
Drugs
fluocinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02359526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359526.